Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBIG for Prevention of Mother-to-infant HBV Transmission
NCT02312531Completed
- Sponsor
- Xi'an Jiaotong University
- Start
- May 2012
- Primary completion
- May 2014
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
01
Overview
Open-label trial of hepatitis B immune globulin in hepatitis B (HBV) (2 arms), sponsored by Xi'an Jiaotong University. Primary endpoints: HBV infection of infants at 1 year and Histopathological changes in placenta. Started May 2012; status: completed.
02
Drugs
hepatitis B immune globulin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02312531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312531.